A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study
<strong>Background</strong> The risk of tuberculosis outbreaks among people fleeing hardship for refuge in Europe is heightened. We describe the cross-border European response to an outbreak of multidrug-resistant tuberculosis among patients from the Horn of Africa and Sudan. <strong...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 语言: | English |
| 出版: |
Elsevier
2018
|
| _version_ | 1826342875862925312 |
|---|---|
| author | Walker, T Merker, M Knoblauch, A Helbling, P Schoch, O van der Werf, M Kranzer, K Fiebig, L Kröger, S Haas, W Hoffmann, H Indra, A Egli, A Cirillo, D Robert, J Rogers, T Groenheit, R Mengshoel, A Mathys, V Haanperä, M van Soolingen, D Niemann, S Böttger, E Keller, P MDR-TB Cluster Consortium |
| author_facet | Walker, T Merker, M Knoblauch, A Helbling, P Schoch, O van der Werf, M Kranzer, K Fiebig, L Kröger, S Haas, W Hoffmann, H Indra, A Egli, A Cirillo, D Robert, J Rogers, T Groenheit, R Mengshoel, A Mathys, V Haanperä, M van Soolingen, D Niemann, S Böttger, E Keller, P MDR-TB Cluster Consortium |
| author_sort | Walker, T |
| collection | OXFORD |
| description | <strong>Background</strong> The risk of tuberculosis outbreaks among people fleeing hardship for refuge in Europe is heightened. We describe the cross-border European response to an outbreak of multidrug-resistant tuberculosis among patients from the Horn of Africa and Sudan. <strong>Methods</strong> On April 29 and May 30, 2016, the Swiss and German National Mycobacterial Reference Laboratories independently triggered an outbreak investigation after four patients were diagnosed with multidrug-resistant tuberculosis. In this molecular epidemiological study, we prospectively defined outbreak cases with 24-locus mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) profiles; phenotypic resistance to isoniazid, rifampicin, ethambutol, pyrazinamide, and capreomycin; and corresponding drug resistance mutations. We whole-genome sequenced all Mycobacterium tuberculosis isolates and clustered them using a threshold of five single nucleotide polymorphisms (SNPs). We collated epidemiological data from host countries from the European Centre for Disease Prevention and Control. <strong>Findings</strong> Between Feb 12, 2016, and April 19, 2017, 29 patients were diagnosed with multidrug-resistant tuberculosis in seven European countries. All originated from the Horn of Africa or Sudan, with all isolates two SNPs or fewer apart. 22 (76%) patients reported their travel routes, with clear spatiotemporal overlap between routes. We identified a further 29 MIRU-VNTR-linked cases from the Horn of Africa that predated the outbreak, but all were more than five SNPs from the outbreak. However all 58 isolates shared a capreomycin resistance-associated tlyA mutation. <strong>Interpretation</strong> Our data suggest that source cases are linked to an M tuberculosis clone circulating in northern Somalia or Djibouti and that transmission probably occurred en route before arrival in Europe. We hypothesise that the shared mutation of tlyA is a drug resistance mutation and phylogenetic marker, the first of its kind in M tuberculosis sensu stricto. |
| first_indexed | 2025-03-11T23:38:13Z |
| format | Journal article |
| id | oxford-uuid:e3be92ea-66a3-4ee0-9969-e9a14c753583 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-03-11T23:38:13Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:e3be92ea-66a3-4ee0-9969-e9a14c7535832025-03-11T14:03:29ZA cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e3be92ea-66a3-4ee0-9969-e9a14c753583EnglishSymplectic Elements at OxfordElsevier2018Walker, TMerker, MKnoblauch, AHelbling, PSchoch, Ovan der Werf, MKranzer, KFiebig, LKröger, SHaas, WHoffmann, HIndra, AEgli, ACirillo, DRobert, JRogers, TGroenheit, RMengshoel, AMathys, VHaanperä, Mvan Soolingen, DNiemann, SBöttger, EKeller, PMDR-TB Cluster Consortium<strong>Background</strong> The risk of tuberculosis outbreaks among people fleeing hardship for refuge in Europe is heightened. We describe the cross-border European response to an outbreak of multidrug-resistant tuberculosis among patients from the Horn of Africa and Sudan. <strong>Methods</strong> On April 29 and May 30, 2016, the Swiss and German National Mycobacterial Reference Laboratories independently triggered an outbreak investigation after four patients were diagnosed with multidrug-resistant tuberculosis. In this molecular epidemiological study, we prospectively defined outbreak cases with 24-locus mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) profiles; phenotypic resistance to isoniazid, rifampicin, ethambutol, pyrazinamide, and capreomycin; and corresponding drug resistance mutations. We whole-genome sequenced all Mycobacterium tuberculosis isolates and clustered them using a threshold of five single nucleotide polymorphisms (SNPs). We collated epidemiological data from host countries from the European Centre for Disease Prevention and Control. <strong>Findings</strong> Between Feb 12, 2016, and April 19, 2017, 29 patients were diagnosed with multidrug-resistant tuberculosis in seven European countries. All originated from the Horn of Africa or Sudan, with all isolates two SNPs or fewer apart. 22 (76%) patients reported their travel routes, with clear spatiotemporal overlap between routes. We identified a further 29 MIRU-VNTR-linked cases from the Horn of Africa that predated the outbreak, but all were more than five SNPs from the outbreak. However all 58 isolates shared a capreomycin resistance-associated tlyA mutation. <strong>Interpretation</strong> Our data suggest that source cases are linked to an M tuberculosis clone circulating in northern Somalia or Djibouti and that transmission probably occurred en route before arrival in Europe. We hypothesise that the shared mutation of tlyA is a drug resistance mutation and phylogenetic marker, the first of its kind in M tuberculosis sensu stricto. |
| spellingShingle | Walker, T Merker, M Knoblauch, A Helbling, P Schoch, O van der Werf, M Kranzer, K Fiebig, L Kröger, S Haas, W Hoffmann, H Indra, A Egli, A Cirillo, D Robert, J Rogers, T Groenheit, R Mengshoel, A Mathys, V Haanperä, M van Soolingen, D Niemann, S Böttger, E Keller, P MDR-TB Cluster Consortium A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title_full | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title_fullStr | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title_full_unstemmed | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title_short | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| title_sort | cluster of multidrug resistant mycobacterium tuberculosis among patients arriving in europe from the horn of africa a molecular epidemiological study |
| work_keys_str_mv | AT walkert aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT merkerm aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT knoblaucha aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT helblingp aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT schocho aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT vanderwerfm aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT kranzerk aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT fiebigl aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT krogers aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT haasw aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT hoffmannh aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT indraa aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT eglia aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT cirillod aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT robertj aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT rogerst aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT groenheitr aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mengshoela aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mathysv aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT haanperam aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT vansoolingend aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT niemanns aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT bottgere aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT kellerp aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mdrtbclusterconsortium aclusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT walkert clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT merkerm clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT knoblaucha clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT helblingp clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT schocho clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT vanderwerfm clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT kranzerk clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT fiebigl clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT krogers clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT haasw clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT hoffmannh clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT indraa clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT eglia clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT cirillod clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT robertj clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT rogerst clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT groenheitr clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mengshoela clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mathysv clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT haanperam clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT vansoolingend clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT niemanns clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT bottgere clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT kellerp clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy AT mdrtbclusterconsortium clusterofmultidrugresistantmycobacteriumtuberculosisamongpatientsarrivingineuropefromthehornofafricaamolecularepidemiologicalstudy |